|
Q2 2018
Filed on Aug 14, 2018
|
1,540,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
1,000,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
1,500,000
|
N/A
|
|
Actinium Pharmaceuticals Inc
|
Q2 2018
Filed on Aug 14, 2018
|
6,100,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
64,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
352,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
200,000
|
$29.49 - $35.05
$5.9M - $7.01M
|
|
|
Q1 2018
Filed on May 15, 2018
|
600,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
212,000
|
$42.6 - $54.55
$9.03M - $11.6M
|
|
|
Q1 2018
Filed on May 15, 2018
|
748,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
613,896
|
N/A
|
|
Ritter Pharmaceuticals Inc
|
Q1 2018
Filed on May 15, 2018
|
1,900,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
3,470,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
800,000
|
$3.15 - $4.99
$2.52M - $3.99M
|
|
|
Q1 2018
Filed on May 15, 2018
|
300,000
|
$20.25 - $23.96
$6.08M - $7.19M
|
|
|
Q1 2018
Filed on May 15, 2018
|
64,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
412,000
|
$36.18 - $40.15
$14.9M - $16.5M
|
|
Anthera Pharmaceuticals Inc
|
Q1 2018
Filed on May 15, 2018
|
768,915
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
128,000
|
$57.9 - $94.36
$7.41M - $12.1M
|
|
|
Q1 2018
Filed on May 15, 2018
|
384,000
|
$8.1 - $16.0
$3.11M - $6.14M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
632,000
|
$8.2 - $13.2
$5.18M - $8.34M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
200,000
|
$12.83 - $16.91
$2.57M - $3.38M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
200,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
840,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
624,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
400,000
|
$15.74 - $21.76
$6.3M - $8.7M
|
|
Momenta Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 14, 2018
|
132,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
100,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
260,000
|
N/A
|
|
Aviragen Therapeutics Inc
|
Q4 2017
Filed on Feb 14, 2018
|
1,378,463
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
2,050,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
816,000
|
N/A
|
|
Adamas Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 14, 2018
|
26,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
500,000
|
$64.57 - $80.25
$32.3M - $40.1M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
464,195
|
N/A
|
|